Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
A Multi-Centric Double-Blind Homoeopathic Pathogenetic Trial Of Cyclosporin, Goutam Rakshit, A Vichitra, Rajpal Rajpal, Sujata Choudhury, Vinay Singh
A Multi-Centric Double-Blind Homoeopathic Pathogenetic Trial Of Cyclosporin, Goutam Rakshit, A Vichitra, Rajpal Rajpal, Sujata Choudhury, Vinay Singh
Indian Journal of Research in Homoeopathy
Objective : To elicit the pathogenetic response of the drug Cyclosporin in homoeopathic potencies on apparently healthy human beings. Material and Methods : The drug Cyclosporin was proved by the Central Council for Research in Homoeopathy through double-blind placebo-controlled trial. The study was conducted in two centres. The drug was proved in two potencies (6C and 30C) on 50 apparently healthy volunteers who were selected after conducting pre-trial medical examinations by the medical specialists and routine laboratory investigations. In the first phase the volunteers were given 56 doses (4 doses per day for 14 days) of placebo. In the next …
A Multi-Centric Double-Blind Randomized Homoeopathic Pathogenetic Trial Of Gymnema Sylvestre, Goutam Rakshit, J Singh, S Pathak, Ch Banoth, P Chandra, Rajpal Rajpal, Sujata Choudhury, Vinay Singh
A Multi-Centric Double-Blind Randomized Homoeopathic Pathogenetic Trial Of Gymnema Sylvestre, Goutam Rakshit, J Singh, S Pathak, Ch Banoth, P Chandra, Rajpal Rajpal, Sujata Choudhury, Vinay Singh
Indian Journal of Research in Homoeopathy
Objective: To elicit the pathogenetic response of Gymnema sylvestre in homoeopathic potencies on apparently healthy human volunteers. Methodology: Gymnema sylvestre was proved by the Central Council for Research in Homoeopathy through double-blind placebo-controlled method. The study was carried out at four centers. The drug was proved in two potencies (6C and 30C) on 63 apparently healthy volunteers who were selected after conducting pre-trial medical examination by the medical specialists and routine laboratory investigations. In the first phase volunteers were given 56 doses (04 doses per day for 14 days) of placebo. In the next two phases 56 doses (04 doses …